)
Shares of small-sized pharmaceutical company Sharon Bio-Medicine were trading higher by 5% at Rs 21.30, extending their past four-days rally on the BSE.
The stock hit a high of Rs 21.80 in intra-day trades today, zooming by 67% in the past one week from Rs 13.05 on July 3, 2015.
With reference to the increase in share price, the company clarified to BSE that the share prices of Sharon Bio-Medicine have already gone down and investors may be looking for the best opportunity to buy the shares at this point.
"The share prices of our company have fallen from Rs 90 per share to Rs 12.50 per share in the last one year. The reason for the fall in the share price was the losses suffered by our company,” the company said.
Hundreds of share investors are being added to our company every week inspite of shares being sold by one of the promoter in the last one month, the company added further.
Meanwhile, on July 9, 2015, the company announced that one of its unit located at L-6, MIDC, Taloja, district Raigad, Maharashtra has been inspected and audited by US Food and Drug Administration (USFDA) inspectors for 7 days starting from June 29, 2015. The audit was completed on July 07, 2015.
The stock hit a high of Rs 21.80 in intra-day trades today, zooming by 67% in the past one week from Rs 13.05 on July 3, 2015.
With reference to the increase in share price, the company clarified to BSE that the share prices of Sharon Bio-Medicine have already gone down and investors may be looking for the best opportunity to buy the shares at this point.
"The share prices of our company have fallen from Rs 90 per share to Rs 12.50 per share in the last one year. The reason for the fall in the share price was the losses suffered by our company,” the company said.
Hundreds of share investors are being added to our company every week inspite of shares being sold by one of the promoter in the last one month, the company added further.
Meanwhile, on July 9, 2015, the company announced that one of its unit located at L-6, MIDC, Taloja, district Raigad, Maharashtra has been inspected and audited by US Food and Drug Administration (USFDA) inspectors for 7 days starting from June 29, 2015. The audit was completed on July 07, 2015.
